The Conference on Retroviruses and Opportunistic Infections (CROI), an annual preeminent HIV research meeting, was held in Boston, Massachusetts, February 22-25, this year. CROI gathers scientists researching epidemiology and biology of human retroviruses and associated diseases to discuss their findings.
This blog post is a collection of hepatitis C (HCV) at CROI 2016 highlights and some 2016 journal articles about HCV/HIV coinfection and treatment.
Sampling of CROI 2016 Abstracts about HIV/HCV Coinfection
- Antiretroviral Use and Implications for DAA Therapy in HIV/HCV Coinfection (Abstract #451)
- Hepatitis C and the Risk of Non-Liver-Related Morbidity and Mortality in HIV+ Persons (Abstract #612)
- Devising a Strategy to Control the HCV Epidemic in British Columbia, Canada (Abstract #533)
- Is HCV Elimination Possible? A Modeling Study of HIV-Positive MSM (Abstract #536)
Hepatitis C Highlights at CROI 2016 according to HIVandHepatitis.com:
- Sofosbuvir/Velpatasvir for Hepatitis C Can Be Administered with Most Antiretrovirals
- Sofosbuvir Demonstrates High Cure Rate for HCV Genotype 4
- Harvoni for 6 Weeks Cures HIV+ People with Acute HCV if Viral Load is Low
Hepatitis C Highlights at CROI 2016 by hepmag.com:
- The Big Hepatitis C News Out of the CROI Medical Conference in Boston
- Hepatitis C Cure is Linked to Lowered Risk of Death, Kidney Disease and Diabetes in Those With HIV
- Liver Fibrosis Severity is Tied to Cognitive Dysfunction in Women Independent of HIV or Hepatitis C Status
- Poorly Controlled HIV is Independently Linked to Liver Fibrosis Progression in Those With and Without Hepatitis C
Hepatitis C Highlights at CROI 2016 according to AIDS.gov:
Recent Articles about HCV/HIV Coinfection and Treatment:
- HCV-HIV co-infected patients: no longer a ‘special’ population?
- Effectiveness of first-generation HCV protease inhibitors: does HIV coinfection still play a role?
- Advantage of pegylated interferon and ribavirin combination therapy in people living with hepatitis C virus/HIV coinfection
- Does Hep C Exposure Raise the Risk of Kidney Disease and Osteoporosis in People With HIV?